Anthony Lakavage is Senior Vice President, Global External Affairs, at USP. In this role, Mr. Lakavage oversees Global Communications, U.S. and International Public Policy and Regulatory Affairs, Global Stakeholder Engagement and the USP Quality Institute. He is the lead architect of the organization’s external engagement strategy and represents USP in a variety of forums involving the U.S. Food and Drug Administration and Congress, international regulatory authorities and ministries of health, professional and trade organizations, non-governmental organizations and the news media.
Mr. Lakavage has worked in numerous segments of the life sciences industry including the pharmaceutical, vaccine, medtech, and clinical laboratory sectors. His experience is geographically diverse and spans the U.S. federal and state level, Europe, global institutions and emerging markets.
Mr. Lakavage brings more than twenty years of demonstrated leadership in public affairs; public policy and government relations; and global health advocacy to his role at USP. Prior to joining USP, Mr. Lakavage served as Worldwide Vice President, Public Affairs, at Becton Dickinson. A biopharmaceutical industry veteran, Mr. Lakavage has held a variety of domestic and international public policy and government affairs leadership roles for GlaxoSmithKline, Chiron Corporation and Applied Biosystems. Earlier in his career, he worked for Pennsylvania Lt. Gov. Mark Singel and Missouri Congressman Alan Wheat.
Mr. Lakavage earned his Bachelor of Arts Degree, cum laude, in International Politics from Saint Joseph's University, and his Juris Doctorate, cum laude, from the Temple University School of Law–where he served on the Temple Political & Civil Rights Law Review staff. He is admitted to the bar in Pennsylvania and New Jersey.